Evidence That the EphA2 Receptor Exacerbates Ischemic Brain Injury

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Thundyil, John ^a   Manzanero, Silvia ^a   Pavlovski, Dale ^a   Cully, Tanya R ^a   Lok, Ker Zhing ^a   Widiapradja, Alexander ^a   Chunduri, Prasad ^a   Jo, Dong Gyu ^b   Naruse, Chie ^c   Asano, Masahide ^c   Launikonis, Bradley S ^a   Sobey, Christopher G ^d   Coulthard, Mark G ^a,e   Arumugam, Thiruma V ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Sungkyunkwan University   (South Korea)

^c KANAZAWA UNIVERSITY   (Japan)

^d MONASH UNIVERSITY   (Australia)

^e ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; EPHRIN RECEPTOR A1; EPHRIN RECEPTOR A2; EPHRIN RECEPTOR A3; GELATINASE B; PROTEIN BAX; PROTEIN BCL 2; PROTEIN ZO1; TRIPHENYLTETRAZOLIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN DAMAGE; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL DEATH; CELL INFILTRATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EMBRYO; ENCEPHALITIS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOLECULAR PATHOLOGY; MOUSE; NERVE CELL; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; SCORING SYSTEM; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE;

ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BLOOD-BRAIN BARRIER; BRAIN INFARCTION; BRAIN ISCHEMIA; CASPASE 3; CEREBRAL CORTEX; EPHRINS; GENE EXPRESSION REGULATION; GLUCOSE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MATRIX METALLOPROTEINASE 9; MICE; NEURONS; RECEPTOR, EPHA2; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TETRAZOLIUM SALTS; ZONULA OCCLUDENS-1 PROTEIN;

MUS;

EID: 84872141120     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053528     Document Type: Article

References (34)

1. Davy A, Soriano P, (2005) Ephrin signaling in vivo: look both ways. Dev Dyn 232: 1-10.
2. Rohani N, Canty L, Luu O, Fagotto F, Winklbauer R, (2011) EphrinB/EphB signaling controls embryonic germ layer separation by contact-induced cell detachment. PLoS Biol 9: e1000597.
3. Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, et al. (1996) Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 17: 9-19.
4. Himanen JP, Nikolov DB, (2003) Eph signaling: a structural view. Trends Neurosci 26: 46-51.
5. Pasquale EB, (2008) Eph-ephrin bidirectional signaling in physiology and disease. Cell 133: 38-52.
6. Du J, Fu C, Sretavan DW, (2007) Eph/ephrin signaling as a potential therapeutic target after central nervous system injury. Curr Pharm Des 13: 2507-2518.
7. Xu H, Tian W, Lindsley JN, Oyama TT, Capasso JM, et al. (2005) EphA2: expression in the renal medulla and regulation by hypertonicity and urea stress in vitro and in vivo. Am J Physiol Renal Physiol 288: F855-866.
8. Blits-Huizinga CT, Nelersa CM, Malhotra A, Liebl DJ, (2004) Ephrins and their receptors: binding versus biology. IUBMB Life 56: 257-265.
9. Himanen JP, Chumley MJ, Lackmann M, Li C, Barton WA, et al. (2004) Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci 7: 501-509.
10. Egea J, Klein R, (2007) Bidirectional Eph-ephrin signaling during axon guidance. Trends Cell Biol 17: 230-238.
11. Kullander K, Klein R, (2002) Mechanisms and functions of Eph and ephrin signalling. Nat Rev Mol Cell Biol 3: 475-486.
12. Baum CL, Arpey CJ, (2005) Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 31: 674-686.
13. Hafner C, Schmitz G, Meyer S, Bataille F, Hau P, et al. (2004) Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin Chem 50: 490-499.
14. Kuijper S, Turner CJ, Adams RH, (2007) Regulation of angiogenesis by Eph-ephrin interactions. Trends Cardiovasc Med 17: 145-151.
15. Genander M, Frisén J, (2010) Ephrins and Eph receptors in stem cells and cancer. Curr Opin Cell Biol 22: 611-616.
16. Hafner C, Meyer S, Langmann T, Schmitz G, Bataille F, et al. (2005) Ephrin-B2 is differentially expressed in the intestinal epithelium in Crohn's disease and contributes to accelerated epithelial wound healing in vitro. World J Gastroenterol 11: 4024-4031.
17. Kitamura T, Kabuyama Y, Kamataki A, Homma MK, Kobayashi H, et al. (2008) Enhancement of lymphocyte migration and cytokine production by ephrinB1 system in rheumatoid arthritis. Am J Physiol Cell Physiol 294: C189-196.
18. Ivanov AI, Romanovsky AA, (2006) Putative dual role of ephrin-Eph receptor interactions in inflammation. IUBMB Life 58: 389-394.
19. Cercone MA, Schroeder W, Schomberg S, Carpenter TC, (2009) EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia. Am J Physiol Lung Cell Mol Physiol 297: L856-863.
20. Larson J, Schomberg S, Schroeder W, Carpenter TC, (2008) Endothelial EphA receptor stimulation increases lung vascular permeability. Am J Physiol Lung Cell Mol Physiol 295: L431-439.
21. Carpenter TC, Schroeder W, Stenmark KR, Schmidt EP, (2012) Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury. Am J Respir Cell Mol Biol 46: 40-47.
22. Zhou N, Zhao WD, Liu DX, Liang Y, Fang WG, et al. (2011) Inactivation of EphA2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells. Microvasc Res 82: 113-121.
23. Arocho LC, Figueroa JD, Torrado AI, Santiago JM, Vera AE, et al. (2011) Expression profile and role of EphrinA1 ligand after spinal cord injury. Cell Mol Neurobiol 31: 1057-1069.
24. Widiapradja A, Vegh V, Lok KZ, Manzanero S, Thundyil J, et al. (2012) Intravenous immunoglobulin protects neurons against amyloid beta-peptide toxicity and ischemic stroke by attenuating multiple cell death pathways. J Neurochem 122: 321-332.
25. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, et al. (2009) Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 40: 1849-1857.
26. Feiler S, Plesnila N, Thal SC, Zausinger S, Schöller K, (2011) Contribution of matrix metalloproteinase-9 to cerebral edema and functional outcome following experimental subarachnoid hemorrhage. Cerebrovasc Dis 32: 289-295.
27. Broughton BR, Reutens DC, Sobey CG, (2009) Apoptotic mechanisms after cerebral ischemia. Stroke 40: e331-339.
28. Goldshmit Y, McLenachan S, Turnley A, (2006) Roles of Eph receptors and ephrins in the normal and damaged adult CNS. Brain Res Rev 52: 327-345.
29. Naruse-Nakajima C, Asano M, Iwakura Y, (2001) Involvement of EphA2 in the formation of the tail notochord via interaction with ephrinA1. Mech Dev 102: 95-105.
30. Thundyil J, Pavlovski D, Hsieh YH, Gelderblom M, Magnus T, et al. (2012) C5a receptor (CD88) inhibition improves hypothermia-induced neuroprotection in an in vitro ischemic model. Neuromolecular Med 14: 30-39.
31. Thundyil J, Tang SC, Okun E, Shah K, Karamyan VT, et al. (2010) Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death. Exp Transl Stroke Med 2: 15.
32. Lin TN, He YY, Wu G, Khan M, Hsu CY, (1993) Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats. Stroke 24: 117-121.
33. Ahmed SH, He YY, Nassief A, Xu J, Xu XM, et al. (2000) Effects of lipopolysaccharide priming on acute ischemic brain injury. Stroke 31: 193-199.
34. Manaenko A, Chen H, Kammer J, Zhang JH, Tang J, (2011) Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model. J Neurosci Methods 195: 206-210.